MariTide Demonstrated up to ~20% Average Weight Loss at 52 Weeks Without a Weight Loss Plateau in People Living With Obesity or Overweight MariTide is the First Obesity Treatment With…

– Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR. Attruby has been shown to preserve the native function of TTR as a transport…

– Acoramidis demonstrated the earliest known time to separation in cardiovascular outcomes in the ATTRibute-CM study (3 months), with statistically significant risk reduction of 36% on All-Cause Mortality (ACM) alone…

In the latest episode of “On the Beat with ABC,” we had the privilege of speaking with Dr. Modele Ogunniyi, a heart failure cardiologist, professor at Emory University, and passionate…

  As the Association of Black Cardiologists (ABC) approaches its 50th anniversary in November 2024, it has initiated a year-long series of forward-thinking events starting with the “Honoring Our Past,…

Pulmonary Hypertension: What You Need to Know Patient Education Sheet Pulmonary hypertension (PH) is a rare and grave chronic condition that affects an estimated 1% of the global population, with…